BioAdaptives Inc. (BDPT)
BioAdaptives Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Las Vegas, NV, US. The stock last traded at $0.00, up 14.29% on the session, giving a market capitalisation of $57,642. On trailing twelve-month figures it carries a trailing P/E of -0.04, a net margin of -4553.7%. Its beta of 1.19 implies it has historically moved more than the broad market.
BioAdaptives, Inc. is a research and development company that develops and markets nutraceutical and dietary supplement products for humans and animals. Its products are derived from natural plant, fungi, and algal-based sources and include supplements for cognitive enhancement, weight management, and regenerative wellness.
BioAdaptives Inc. is most often compared with the following Healthcare names: